Скачать с ютуб Democratizing Access to Early-stage Healthcare Investments - Neill Littman, Bioverge @Synchrony2021 в хорошем качестве

Democratizing Access to Early-stage Healthcare Investments - Neill Littman, Bioverge @Synchrony2021

Neil Littman, MS, is Founder & CEO of Bioverge, a venture capital firm exclusively dedicated to investing in early-stage, cutting-edge healthcare companies. Bioverge’s investment thesis is focused on companies spanning the intersection of health + tech that are utilizing advances in technology to modernize healthcare, from bench-to-bedside. Previously, Neil was Vice President of Business Development at Notable Labs, an oncology startup and Bioverge portfolio company, where he led the development of global corporate partnerships and contributed to the strategic vision of Notable as part of the Senior Leadership Team. Neil oversaw business development at Notable through the successful completion of the company’s $40 million Series B. Previously, Neil was a member of the Executive Leadership Team and Director of Business Development at the California Institute for Regenerative Medicine. Prior to CIRM, Neil was a healthcare investment banker at Thomas Weisel Partners and Deutsche Bank and worked on transactions totaling over $1 billion. His primary focus was on strategic advisory and  public and private financings. Neil received a Master of Science in Biotechnology from The Johns Hopkins University. Bioverge is an investment platform and syndicate that connects individual investors with highly curated investment opportunities at the intersection of health + tech (or TechBio): "We help our members invest in the health-related causes they care about most and we help companies bridge the valley of death. At Bioverge, we believe we can all do well by doing good." 🎥 This talk was part of Synchrony 2021 Online Symposium - 'From Bench to Biopharma', organised by the The BRAIN Foundation in partnership with UC Davis MIND Institute and CalTech. 🎥 For more Synchrony 2021 talks and highlights:    • Synchrony Symposium 2021 - From Bench...   🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 Synchrony https://synchronysymposium.com/ is the first and only international symposium on translational research in #autism, that brings together academia, #biotech, pharmaceutical companies and #venture partners from around the world with the mission to improve health and quality of life of people with #autismspectrumdisorder. 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 The BRAIN Foundation https://brainfoundation.org/ is a 501c(3) non-profit. The founders of BRAIN envision a world where every child and adult on the autism spectrum is healthy, participates fully in education and employment, and has a better quality of life. It aims to catalyze research that results in evidence-based interventions for the disabilities associated with autism, and also results in better medical standard of care. To accomplish this, it funds impactful research through #philanthropy and our network of partners in the venture, corporate, and grassroots community.